Milligrams vs. Effect: How Dose-Response Works for Supplements Like MemoHoney
Supplement effects follow dose-response curves: below a threshold there is little measurable change, through a working range the effect rises, and past a ceiling it flattens while side effects climb. MemoHoney's amino acid doses sit below the range where trials measure effects, so any benefit is expected to be small and cumulative rather than absent or dramatic.
- Effects are curves, not switches
- MemoHoney sits below the measured range
- Daily intake accumulates in substrate pools
- More is not linearly better
The shape of a dose-response curve
Nearly every bioactive follows an S-shaped curve. At very low doses the body's existing supply and regulatory systems absorb the addition without measurable change. Through the middle, response rises steeply with dose. Near the top, receptors or enzymes saturate and extra intake yields little — while side effects, which often follow their own curve, keep rising. Where a product sits on that curve determines everything about what to expect from it.
Where MemoHoney's ingredients sit
Nitric oxide synthase is not normally saturated with arginine, so adding substrate can raise output — but the enzyme's affinity means large increases in plasma arginine are needed for measurable vascular change, which is why trials use grams. MemoHoney's ~600 mg adds to a dietary background of 4–6 g; the proportional increase is real but small. Niacin is different: its curve is about correcting a shortfall, and 7.5 mg NE moves an under-supplied person well up that curve. Beta-Alanine at 40 mg sits so far below threshold that its position on the curve is effectively the origin.
Why "more" stops helping
Above roughly 6 g of citrulline, additional intake does not further raise nitric oxide markers in most studies, and GI side effects rise. Above 35 mg of supplemental niacin, flushing and, at much higher doses, liver strain appear. Dose-response is the argument against megadosing as much as against underdosing. The goal is the working range, not the maximum.
Cumulative effects and the 60-day logic
A sub-threshold daily dose is not nothing when the target is a pool rather than a peak. Daily citrulline and arginine modestly raise the baseline substrate available to endothelial cells; daily niacin maintains NAD synthesis. Effects of that kind are noticed as gradual trends over weeks, not as an event after one capsule — which is exactly the pattern buyer reviews describe, and exactly why a 60-day evaluation window is the right test.
What this means for MemoHoney
MemoHoney is a low-on-the-curve, daily-accumulation formula. That is a legitimate product category, provided the marketing says so — and this site does.
| Ingredient | Per capsule | Research / RDA range |
|---|---|---|
| Niacin (Vitamin B3) | 7.5 mg NE | 14–16 mg NE (RDA) |
| Calcium | 18 mg | 1,000–1,200 mg (RDA) |
| L-Arginine (base) | 200 mg | 3,000–6,000 mg |
| L-Arginine AKG 2:1 | 200 mg | 3,000–6,000 mg |
| L-Citrulline HCl | 100 mg | 3,000–8,000 mg |
| L-Citrulline Malate | 100 mg | 3,000–8,000 mg |
| Beta-Alanine | 40 mg | 2,000–6,000 mg |
Every MemoHoney amount is printed on the label — no proprietary blend. Full analysis on the ingredients page; mechanism on how it works.
Key takeaways
- Small doses produce small, not zero, effects — and they accumulate.
- MemoHoney's amino acids sit below the trial-measured range.
- Niacin is the ingredient closest to its working range.
FAQ
Three capsules is still under the research range for the amino acids, triples the cost, and triples the blood-pressure-lowering direction. The formula is not designed for that.
Physiologically, yes — substrate availability rises modestly. Whether that reaches a level you notice varies by person, which is what the guarantee window is for.
Yes. Exercise upregulates nitric oxide synthase, and sleep and hydration affect perfusion. They shift the whole curve more than the supplement does.